Modular facility proof-of-concept for multi-modal bioprocessing activities
In the context of a more globalized world and as shown in pandemic situations such as #COVID19, pharmaceutical manufacturing must adapt to fluctuations in demand, newly approved treatments, or new multimodal activities and platforms. Modular drug #manufacturing facilities can help to provide that flexibility.
In Vaccine Insights, a new peer-reviewed, open-access journal on the development and manufacture of vaccines, Jerome Dalin and G-CON’s Thomas Hauser propose a proof-of-concept to build a standardized and competitive solution for multimodal biologic manufacturing in 12 months.
Watch the video or read the poster below to learn more:
– Why modular, multimodal bioprocessing is an important future trend
– The specific design and timelines for the proof-of-concept facility design
– How this modular facility approach can be leveraged for your specific requirements
– About a roadmap for the future, including improved sustainability and greater automation
Senior Consultant, EMEA Traditional Modalities at Bioprocessing Strategy Operationalization
Jérome Dalin holds an Msc/engineering degree in industrial manufacturing and biological engineering. He is Senior Consultant - EMEA Traditional Modalities, Bioprocessing Strategy Operationalization for Merck KGaA, Life Science, Germany/MilliporeSigma.
He started his career at Sanofi Pasteur 20 years ago, working in France on vaccine process development. In 2013, he joined our company to manage bioprocessing sales with vaccine project coordination at a global level. In his current role, Jérome is leading strategic initiatives and supporting go-to-market strategies with a special focus on traditional modalities.
He started his career at Sanofi Pasteur 20 years ago, working in France on vaccine process development. In 2013, he joined our company to manage bioprocessing sales with vaccine project coordination at a global level. In his current role, Jérome is leading strategic initiatives and supporting go-to-market strategies with a special focus on traditional modalities.
Latest posts by Jérome Dalin (see all)
Business Development Manager at G-CON
Thomas Hauser is Business Development Manager for G-CON Manufacturing within the EMEA region. He works to educate the market for offsite prefabricated and prequalified factory and clean-room solutions in a drive to bring forward the pharmaceutical facility of the future. He also supports companies in the life science segment, mainly for expansion strategies, strategic facility implementation, start-up support, and pharmaceutical packaging supply and technologies. Before 2020, Thomas worked in various leading global positions, dealing with the global life science Industry.
Latest posts by Thomas Hauser (see all)
